Comparative Study
doi: 10.1007/978-3-642-68507-1_26.
Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography
- PMID: 6983979
- DOI: 10.1007/978-3-642-68507-1_26
Item in Clipboard
Comparative Study
Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography
Exp Brain Res.
1982.
No abstract available
Similar articles
-
Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study.J Neurol Sci. 1994 May;123(1-2):11-7. doi: 10.1016/0022-510x(94)90197-x. J Neurol Sci. 1994. PMID: 8064302
-
[Cerebral glucose metabolism in dementia (PET-FDG study)].Rinsho Hoshasen. 1989 Oct;34(11):1343-8. Rinsho Hoshasen. 1989. PMID: 2601096 Japanese.
-
Characteristics of cerebral glucose utilization in dementia.Sci Rep Res Inst Tohoku Univ Med. 1990 Dec;37(1-4):11-21. Sci Rep Res Inst Tohoku Univ Med. 1990. PMID: 2103655
-
Positron emission tomographic studies of local cerebral glucose metabolism in humans in physiological and pathophysiological conditions.Adv Metab Disord. 1983;10:135-76. doi: 10.1016/b978-0-12-027310-2.50010-4. Adv Metab Disord. 1983. PMID: 6364712 Review. No abstract available.
-
Positron emission tomography in dementia.Semin Neurol. 1989 Dec;9(4):338-44. doi: 10.1055/s-2008-1041343. Semin Neurol. 1989. PMID: 2701778 Review. No abstract available.
Cited by
-
Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Alzheimers Res Ther. 2013 Jul 8;5(Suppl 1):S3. doi: 10.1186/alzrt199. Epub 2013 Jul 8. Alzheimers Res Ther. 2013. PMID: 24565260 Free PMC article.
-
Portable PET probes are a novel tool for intraoperative localization of tumor deposits.Ann Surg Innov Res. 2009 Feb 21;3:2. doi: 10.1186/1750-1164-3-2. Ann Surg Innov Res. 2009. PMID: 19232133 Free PMC article.
-
Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer's disease: why it is time to abandon the approach.Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):225-230. doi: 10.1007/s00259-019-04564-5. Eur J Nucl Med Mol Imaging. 2020. PMID: 31673787 No abstract available.
-
FDG-PET for early assessment of Alzheimer's disease: isn't the evidence base large enough?Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1604-9. doi: 10.1007/s00259-010-1535-9. Eur J Nucl Med Mol Imaging. 2010. PMID: 20582541 Review. No abstract available.
-
Combination of triheptanoin with the ketogenic diet in Glucose transporter type 1 deficiency (G1D).Sci Rep. 2023 Jun 2;13(1):8951. doi: 10.1038/s41598-023-36001-x. Sci Rep. 2023. PMID: 37268656 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical